Search clinical trials for: Deceased Donor Kidney

Total 18199 results

University of California, Los Angeles

Recruiting

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Bladder Cancer | Kidney Failure | Bladder, Neurogenic | Bladder Disease

United States
argenx

Recruiting

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function (VARVARA)

Delayed Graft Function

Australia, Spain, Belgium, France, Portugal, Canada
Hansa Biopharma AB

Recruiting

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (DINKY)

Kidney Transplantation in Highly Sensitized Patients

Spain, Finland, Sweden
Hansa Biopharma AB

Recruiting

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys (ConfIdeSLTFU)

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Recruiting

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (PAES)

Kidney Transplantation in Highly Sensitized Patients

Germany, Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
Université de Sherbrooke
McMaster University

Recruiting

Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) (CINERGY)

Ischemic Reperfusion Injury | Brain Death | Organ Transplant Failure or Rejection

Canada
Hansa Biopharma AB

Recruiting

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)

Kidney Transplantation in Highly Sensitized Patients

United States
Washington University School of Medicine
University of Texas; CareDx

Recruiting

Allosure in Simultaneous Pancreas Kidney Transplant

Kidney Pancreas Transplant

United States
Institute for Clinical and Experimental Medicine

Completed

Molecular Markers of Acute Kidney Injury in Elderly Deceased Donors (MoliDon)

Kidney Transplantation | Acute Kidney Injury

Czechia
University of Miami

Completed

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

Renal Transplantation

United States
Tambi Jarmi

Withdrawn

Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)

Ischemia Reperfusion Injury

United States
West China Hospital

Completed

Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation

Kidney Transplantation | Organ Preservation

China
St. Louis University
Washington University School of Medicine; Mid-America Transplant

Completed

Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies

Renal Transplant | Kidney Transplant

United States
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation

Completed

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

Kidney Transplant

United States, Canada
University of California, San Francisco
Oregon Health and Science University

Completed

Deceased Organ Donor Interventions to Protect Kidney Graft Function

Brain Death | Organ Donation | Delayed Graft Function | Organ Transplant Failure or Rejection

United States
Stanford University

Enrolling by invitation

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment

Immune Tolerance

United States
Viela Bio

Withdrawn

Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor

Highly Sensitized Patients on Waiting List for Kidney Transplantation

United States
University of Edinburgh
Kidney Cancer UK

Terminated

Heme Arginate in Transplantation Study (HOT2)

Renal Transplant Rejection | Renal Transplant Failure

United Kingdom
University of Maryland, Baltimore
Living Legacy Foundation

Completed

Novel Strategies for Innovating Deceased Donor Procurement

Kidney Failure, Chronic

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Delayed Graft Function

United States
Columbia University

Completed

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

Implant or Graft; Rejection

United States
Yale University
Johns Hopkins University; National Institute of Diabetes and Digestive and...

Completed

Deceased Donor Biomarkers and Recipient Outcomes (DDS)

End Stage Renal Disease | Acute Kidney Injury | Graft Failure | Delayed Graft Function | Deceased Donor Kidney Transplant

United States
University of Giessen
Novartis; Astellas Pharma US, Inc.; German Cancer Research Center; Heidelberg University

Completed

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Kidney Transplantation | Immunology | Virus | Living Donors | Rituximab (RTx)

Germany
Schroppel, Bernd, M.D.
Alexion Pharmaceuticals

Terminated

A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant

Delayed Function of Renal Transplant

United States
Alexion Pharmaceuticals

Completed

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Stage V Chronic Kidney Disease

Australia, France, Italy, Spain, United Kingdom, Sweden
Stanley Jordan, MD
Genentech, Inc.

Completed

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

End Stage Renal Disease

United States
Virginia Commonwealth University
Health Resources and Services Administration (HRSA)

Completed

Communicating About Choices in Transplantation (COACH)

End Stage Renal Disease and Kidney Transplantation

United States
Mayo Clinic
Alexion Pharmaceuticals

Terminated

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

Kidney Transplant

United States
Helio Tedesco Silva Junior
Sanofi; Novartis

Completed

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Kidney Transplantation | Cytomegalovirus

Brazil
Johns Hopkins University

Terminated

Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates

Kidney Failure

United States
Samsung Medical Center

Completed

Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation

Deceased Donor Kidney Transplantation | Living Donor Kidney Transplantation

Korea, Republic of
University Health Network, Toronto

Completed

Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation (EDM)

Kidney Failure

Canada
Yonsei University

Completed

A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Transplantation - A Prospective, Randomized Trial

End Stage Renal Disease

Korea, Republic of
University of Medicine and Dentistry of New Jersey

Completed

Remote Ischemic Preconditioning In Abdominal Organ Transplantation (RIPCOT)

Liver Disease | Pancreas Disease | Kidney Disease

United States
University of Miami

Completed

Desensitization Protocol for Deceased Donor List

Transplant; Failure, Kidney

United States
Seoul National University Hospital
Roche Pharma AG

Unknown

Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant

End Stage Renal Disease

Korea, Republic of
University of California, San Francisco
California Transplant Donor Network

Completed

Intensive Insulin Therapy in Deceased Donors

Kidney Transplant

United States
Federal University of São Paulo

Unknown

Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

Cytomegalovirus Infections | Disorder of Transplanted Kidney

Brazil
West Penn Allegheny Health System

Completed

Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation

Delayed Graft Function

United States
Fenerbahce University

Not yet recruiting

Progressive Relaxation Exercises for Kidney Donors

Muscle Relaxation | Kidney Transplant; Complications
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Kidney Perfusion With or Without Absorption (POWER)

Kidney Replacement

Italy
University Hospital, Rouen

Not yet recruiting

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R) (BELA-M-R)

Kidney Transplant Rejection
34 Lives, PBC
University of Miami; University of Wisconsin, Madison; MOUNT SINAI HOSPITAL; Indiana...

Recruiting

A Central Preservation and Assessment Service to Optimize Donor Kidney Allocation (OPTIMAL)

Organ Preservation

United States
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

Hiv

United States
Lorenzo delSorbo

Not yet recruiting

Prone Positioning in Neurologically Deceased Potential Organ Donors to Improve Donor Lung Function and Lung Transplant Recipient Outcomes (P-POD)

Lung Transplant Failure

Canada
Seoul National University Hospital
Severance Hospital

Recruiting

Kidney Volume in Live Donors Kidney Transplant Donors and Recipients

Kidney Transplant; Complications

Korea, Republic of
Patrick Schjelderup
Aarhus University Hospital

Not yet recruiting

Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing (MpRenal)

Kidney Transplantation | Living Donors | Senescence | Renal Fibrosis | Multiparametric Magnetic Resonance Imaging
Temple University
Cooperman Barnabas Medical Center

Not yet recruiting

Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3 (EPPComm)

End Stage Renal Disease | Kidney Disease, Chronic | Kidney Replacement

United States
State University of New York - Upstate Medical...

Not yet recruiting

Effect of Probiotics on Immunosuppressive-drug-associated Diarrhea Among Renal Transplant Recipients

Renal Transplantation
Medical University of Warsaw

Recruiting

Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial (HemoCava)

Liver Transplant; Complications

Poland

Search clinical trials for: Deceased Donor Kidney

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations